Abstract
Ischemia and reperfusion injury (IRI) is a complex pathophysiological phenomenon, inevitable in kidney transplantation and one of the most important mechanisms for non- or delayed function immediately after transplantation. Long term, it is associated with acute rejection and chronic graft dysfunction due to interstitial fibrosis and tubular atrophy. Recently, more insight has been gained in the underlying molecular pathways and signalling cascades involved, which opens the door to new therapeutic opportunities aiming to reduce IRI and improve graft survival. This review systemically discusses the specific molecular pathways involved in the pathophysiology of IRI and highlights new therapeutic strategies targeting these pathways.
Reference219 articles.
1. Disease Burden and Mortality Estimates,2015
2. Worldwide access to treatment for end-stage kidney disease: a systematic review
3. Global Observatory on Donation and Transplantation
http://www.transplant-observatory.org
4. Donation After Cardiac Death: The University of Wisconsin Experience with Renal Transplantation
5. Renal transplantation from non-heart-beating donors: A review of the European experience;Koffman;J. Nephrol.,2003
Cited by
182 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献